Adj.prof. Merja Haaparanta-Solin - UTU Research Portal

Merja Haaparanta-Solin
Adj.prof.

- Docent,
Institute of Biomedicine (Faculty of Medicine)

MediCity Research Laboratories, PET

merja.haaparanta-solin@utu.fi

+358 40 715 1742

Tykistökatu 6

Turku

: https://orcid.org/0000-0002-3602-4587

3 of 15

Basal and cold-induced fatty acid uptake of human brown adipose tissue is impaired in obesity (2020)
- Scientific Reports
Saari TJ, Raiko J , U-Din M, Niemi T, Taittonen M, Laine J, Savisto N, Haaparanta-Solin M, Nuutila P, Virtanen KA.
Comparison of high and low molar activity TSPO tracer [18F]F-DPA in a mouse model of Alzheimer’s disease (2020)
- Journal of Cerebral Blood Flow and Metabolism
Keller T., López-Picón F.R., Krzyczmonik A., Forsback S., Takkinen J.S., Rajander J., Teperi S., Dollé F., Rinne J.O., Haaparanta-Solin M., Solin O.
Ruthenium-Mediated 18F-Fluorination and Preclinical Evaluation of a New CB1 Receptor Imaging Agent [18F]FPATPP (2020)
- ACS Chemical Neuroscience
Lahdenpohja S, Rajala N, Helin JS, Haaparanta-Solin M, Solin O, López-Picón FR, Kirjavainen A
[18F]SPA-RQ/PET Study of NK1 receptors in the Whole Body of Guinea Pig and Rat (2019)
- Scientific Reports
Tove J. Grönroos, Sarita Forsback, Olli Eskola, Jörgen Bergman, Päivi Marjamäki, Eliisa Löyttyniemi, Jarmo Hietala, Merja Haaparanta-Solin, Olof Solin
Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation (2019)
- EJNMMI Research
Vainio SK, Dickens AM, Tuisku J, Eskola O, Solin O, Loyttyniemi E, Anthony DC, Rinne JO, Airas L, Haaparanta-Solin M
Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)
- Scientific Reports
Anniina Snellman, Jatta S. Takkinen, Francisco R. López-Picón, Olli Eskola, Olof Solin, Juha O. Rinne, Merja Haaparanta-Solin
Effects of short-term sprint interval and moderate-intensity continuous training on liver fat content, lipoprotein profile, and substrate uptake: a randomized trial (2019)
- Journal of Applied Physiology
Kumail K. Motiani, Anna M. Savolainen, Jussi Toivanen, Jari-Joonas Eskelinen, Minna Yli-Karjanmaa, Kirsi A. Virtanen, Virva Saunavaara, Marja A. Heiskanen, Riitta Parkkola, Merja Haaparanta-Solin, Olof Solin, Nina Savisto, Eliisa Löyttyniemi, Juhani Knuuti, Pirjo Nuutila, Kari K. Kalliokoski, Jarna C. Hannukainen
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients with First-Episode Psychosis (2019)
- JAMA Psychiatry
Borgan F., Laurikainen H., Veronese M., Marques T.R., Haaparanta-Solin M., Solin O., Dahoun T., Rogdaki M., Salokangas R.K.R., Karukivi M., Di Forti M., Turkheimer F., Hietala J., Howes O.
In vivo characterization of a novel norepinephrine transporter PET tracer [18F]NS12137 in adult and immature Sprague-Dawley rats (2019)
- Theranostics
López-Picón F, Kirjavainen AK, Forsback S, Takkinen JS, Peters D, Haaparanta-Solin M, Solin O
Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine (2019)
- Molecular Imaging and Biology
Krzyczmonik A., Keller T., López-Picón F., Forsback S., Kirjavainen A.K., Takkinen J.S., Wasilewska A., Scheinin M., Haaparanta-Solin M., Solin O.